|
|
 |
 |
|
 |
|
|
 |
| |
| ApotheCom |
| |
800 Township Line Road, Suite 100, Yardley, PA 19067
+1 (215) 497 8800
+1 (215) 497 8801
david.dunn@apothecomhh.com
www.apothecomhh.com
|
|
|
|
Philadelphia, PA
San Francisco, CA
|
| |
David Dunn (pictured), CEO
Donna Calvani, President, Yardley
Beth Kamp, PharmD, Senior Vice President
Beth McMahon-Wise, Senior Vice President
Bianca Ruzicka, Senior Vice President
|
| |
| 1999 |
| US/International, part of Huntsworth PLC |
| |
Part of Huntsworth Health global family of brands: Axiom, Brand Health, Curatio, evoke interaction nitrogen, nitrogen interactive, Tonic.
|
| |
|
150+
|
|
150+
|
| |
David Dunn
david.dunn@apothecomhh.com
|
| |
|
|
|
Global or domestic, mass-audience or highly specialized, ApotheCom has a rich
heritage of success in delivering every aspect of scientific communications.
From scientific platform development and advocacy engagement through to content
creation and dissemination, ApotheCom combines science with creativity to deliver
unique and impactful initiatives that reflect a true understanding of the needs of our
clients and their audiences.
|
| |
- Genentech
- Gilead
- Merck/Schering-Plough
- Novartis
- Roche
Medical communications to include publication planning; communications planning/workshops; advisory boards; speaker training; KOL advocacy; medical writing; market research (primary/secondary); promotional services; and event planning.
|
| |
|
|
|
ApotheCom’s core competency is medical communications; from publications to advocacy development through peer-to-peer education. We are adept at strategic consultancy, tactical
planning, and program management. We provide adaptable innovative solutions to address our clients’ needs.
It is important to remember that in the pharmaceutical industry nothing is certain except for change. Although we may currently support activities within a specific therapeutic category, one negative clinical trial can irreparably change the potential of an agent. As a result, we continue to pursue opportunities across all disease states and with multiple clients. In this way we proactively plan for our financial success
|
| |
|
|
ApotheCom was founded with the vision of providing a full spectrum of services to its clients supporting the entire life cycle of their products at a global, regional, and local level. Because we understand how to link messaging and science, we are able to provide a full spectrum of
programming expertise. Our internal teams have a broad base of knowledge in multiple therapeutic categories and include: cardiovascular, dermatology, diabetes/metabolism, gastroenterology, hepatology, immunology, neurosciences, oncology, pain, respiratory, urology, and women’s health
|
| |
|
|
ApotheCom offerings include an expertise in publication and communication services needed throughout a product’s life cycle, from unmet need and disease awarenessbuilding to preclinical, pivotal, and phase IV/postmarketing publications
|
| |
|
|
|
Global Finalist Award
2008 From Risk to Failure: Sleep Apnoea and the Failing Heart, HFSA – Heart Failure Society of America & Respironics
2007 Targeting Patient & Partner Satisfaction, Pfizer
2005 Alcoholism: Translating Emerging Science into Clinical Practice, Alkermes
2005 Therapeutic Approaches in Hematologic Malignancies, CTI
IN-AWE Award
2006 Bridging the Management Gap: a Practical Approach to Sleep Apnoea & Heart Failure, Respironics
2005 Clinical Genomics Progress & Challenges, Genomic Health
|
| |
|
Based on project budget fees and/or management fees
|
| |
Company Advertisement:
Click on the image for a larger view
|
| |
 |
|
|
|
|
|
